Brady (BRC) Q2 2025 earnings summary

Executive summary

• Q2 FY2025 sales increased 10.6% to $356.7M, with 2.6% organic growth and 10.2% from acquisitions, partially offset by a 2.2% FX headwind.

• Adjusted Diluted EPS rose 7.5% to $1.00, while GAAP Diluted EPS declined to $0.83 due to amortization and reorganization costs.

• Net income for Q2 FY2025 was $40.3M, down from $43.6M YoY; Adjusted Net Income was $48.1M, up from $45.4M.

• Americas and Asia delivered strong organic sales growth of 4.3% and adjusted operating income growth of 12%.

• Acquisitions of Gravotech and AB&R expanded product offerings and contributed to sales growth.

Financial highlights

• Gross margin for Q2 FY2025 was $175.8M, up from $162.1M YoY, but margin rate decreased to 49.3% from 50.2% due to facility closures and acquisition costs.

• Adjusted net income rose 5.9% to $48.1M; operating cash flow was $39.6M, and free cash flow improved to $32.5M from a negative $13.5M last year.

• Cash and cash equivalents at quarter-end were $138.5M, with $210.1M available under the credit agreement.

• Operating margin for Q2 was 14.4%, down from 16.7% YoY.

• Net cash position of $50.8M as of January 31, up $21.7M sequentially.

Outlook and guidance

• Raised the low end of full-year adjusted diluted EPS guidance to $4.45–$4.70, representing 5.5%–11.4% growth over FY24.

• GAAP EPS guidance updated to $3.99–$4.24, reflecting facility closure and reorganization costs.

• Expecting low single-digit organic sales growth for FY25; full-year CapEx expected at $35M; income tax rate at 21%.

• Financial resources and liquidity are considered sufficient to support growth strategy and manage potential economic or geopolitical impacts.